TOKYO/BEIJING/BRUSSELS -- China is on the verge of expanding its international influence as it adroitly wields what is arguably the most valuable export of the moment, COVID-19 vaccines.
The global rollout of Chinese jabs amid a serious shortage of doses, especially in low- and middle-income countries, is helping Beijing attain a new kind of soft power that could easily translate into global clout. At least 70 countries and territories have either approved Chinese vaccines or struck deals to receive doses from China.
%E7%B8%AE%E3%82%80%E5%BB%BA%E8%A8%AD%E6%A5%AD-1.jpg?width=178&fit=cover&gravity=faces&dpr=2&quality=medium&source=nar-cms&format=auto&height=100)
